XML 56 R35.htm IDEA: XBRL DOCUMENT v3.23.3

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):

			Three Months Ended September 30,												Nine Months Ended September 30,
			2023						2022						2023						2022
Basic:
Net income attributable to Edwards Lifesciences Corporation			$	384.9					$	343.5					$	1,032.5					$	1,123.5
Weighted-average shares outstanding			607.0						619.8						607.2						621.0
Basic earnings per share			$	0.63					$	0.55					$	1.70					$	1.81
Diluted:
Net income attributable to Edwards Lifesciences Corporation			$	384.9					$	343.5					$	1,032.5					$	1,123.5
Weighted-average shares outstanding			607.0						619.8						607.2						621.0
Dilutive effect of stock plans			2.5						4.7						3.0						5.9
Dilutive weighted-average shares outstanding			609.5						624.5						610.2						626.9
Diluted earnings per share			$	0.63					$	0.55					$	1.69					$	1.79

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration